High and low serum potassium associated with cardiovascular events in diuretic-treated patients

被引:35
作者
Cohen, HW [1 ]
Madhavan, S [1 ]
Alderman, MH [1 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA
关键词
serum potassium; cardiovascular disease events; hypertension; diuretic use;
D O I
10.1097/00004872-200107000-00018
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To determine the relationship of moderately high and low concentrations of serum potassium with cardiovascular disease events among treated hypertensive patients. Design An observational cohort study with prospectively collected data. Setting A worksite treatment program for mild hypertension. Patients All program participants with baseline and at least one annual follow-up measure of serum potassium; 7653 individuals with 6.7 years mean follow-up met these criteria. Main outcome measures Outcome events were admissions to hospital because of cardiovascular disease, and deaths. The research question regarding serum potassium categories was formulated after data collection. The serum potassium concentration (mean +/- 2SD) of the study population was used to define low (3.0-3.5 mmol/l), high (5.1 - 5.9 mmol/l) and middle (3.6 - 5.0 mmol/l) categories. Results Individuals with low (n = 146) and high (n = 226) serum potassium had significantly greater risk for cardiovascular disease events than those in the middle category (n = 7281). Multivariate adjusted hazard ratios from Cox models were 2.6 [95% confidence intervals (CI) 1.5-4.4] for the low potassium group and 1.7 (95% CI 1.02.7) for the high potassium group, with the middle group as reference. Among 1679 individuals who regularly took diuretics, hazard ratios were 4.3 (95% CI 2.4-7.9) for the low potassium group and 6.7 (95% CI 2.8-15.9) for the high group. Neither low nor high potassium was significantly associated with outcome events for those not regularly using diuretics. Conclusions These data confirm an association of mild hypokalemia with increased cardiovascular events among diuretic-treated hypertensive patients. In addition, we have found a similar increased cardiovascular risk associated with modest hyperkalemia among these patients. Whether modification of these serum potassium concentrations would alter that risk remains to be determined. I Hypertens 19:1315-1323 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:1315 / 1323
页数:9
相关论文
共 25 条
  • [1] TREATMENT-INDUCED BLOOD-PRESSURE REDUCTION AND THE RISK OF MYOCARDIAL-INFARCTION
    ALDERMAN, MH
    OOI, WL
    MADHAVAN, S
    COHEN, H
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (07): : 920 - 924
  • [2] DETECTION AND TREATMENT OF HYPERTENSION AT WORK SITE
    ALDERMAN, MH
    SCHOENBAUM, EE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (02) : 65 - 68
  • [3] Serum uric acid and cardiovascular events in successfully treated hypertensive patients
    Alderman, MH
    Cohen, H
    Madhavan, S
    Kivlighn, S
    [J]. HYPERTENSION, 1999, 34 (01) : 144 - 150
  • [4] [Anonymous], 1988, ARCH INTERN MED, V148, P1023
  • [5] DIURETICS, SERUM POTASSIUM AND VENTRICULAR ARRHYTHMIAS IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL
    COHEN, JD
    NEATON, JD
    PRINEAS, RJ
    DANIELS, KA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (07) : 548 - 554
  • [6] BLOOD-PRESSURE AND CORONARY HEART-DISEASE
    COLLINS, R
    PETO, R
    GODWIN, J
    MACMAHON, S
    [J]. LANCET, 1990, 336 (8711) : 370 - 371
  • [7] COX DR, 1972, J R STAT SOC B, V34, P187
  • [8] Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program
    Franse, LV
    Pahor, M
    Di Bari, M
    Somes, GW
    Cushman, WC
    Applegate, WB
    [J]. HYPERTENSION, 2000, 35 (05) : 1025 - 1030
  • [9] MALIGNANT ARRHYTHMIAS IN RELATION TO VALUES OF SERUM POTASSIUM IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    FRIEDENSOHN, A
    FAIBEL, HE
    BAIREY, O
    GOLDBOURT, U
    SCHLESINGER, Z
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1991, 32 (03) : 331 - 338
  • [10] GABOW PA, 1986, RENAL ELECTROLYTE DI, P231